4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-24-047808
CEO and Director acquired 42,553 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meckler Jeffrey A CEO and Director | 2024-11-25 | Grant or award | +42,553 | $1.18 | $50,000 | 202,859 | D |
| Derivatives | |||||||
| Meckler Jeffrey A CEO and Director | 2024-11-25 | Grant or award · Common Stock Warrants | +42,553 | $1.18 | $50,000 | 42,553 | D |
Loading xslF345X05/ownership.xml…